Tufts University Investment Office

Tufts University, founded in 1852 and located in Boston, Massachusetts, is a moderately sized institution known for its strong research programs and commitment to providing a personal educational experience. It operates as a blend of a research university and a liberal arts college, attracting a diverse community of students and faculty who thrive in an environment of creativity and engagement. The university is dedicated to the creation and application of knowledge, offering transformational experiences that foster active citizenship among its scholars. Notably, the Tufts Center for the Study of Drug Development conducts important research to enhance the efficiency and quality of pharmaceutical development, while the Tufts University School of Medicine has been a national leader in medical education since 1893, offering innovative curricula that integrate training in various fields including public health and technology. Additionally, the Tufts University Investment Office oversees the management of the university’s endowment fund, which actively invests in a range of alternative assets.

Antje Danielson

Director

Michael Halassa

Director of Institutional Research at Department of Neuroscience

1 past transactions

Quanterix

Series D in 2016
Quanterix Corporation is a life sciences company focused on developing an advanced platform for single-molecule analysis, known for its ultra-sensitive digital immunoassay technology. This innovative approach enables precise detection and quantification of individual proteins and small molecules in complex biological samples, which is critical for clinical diagnostics, drug development, and life science research. Quanterix's flagship technology, Simoa, allows for the reliable measurement of protein biomarkers in extremely low concentrations, surpassing conventional immunoassay methods. The company offers a range of products, including assay kits, specialized assays for neurodegenerative diseases, and advanced instrumentation designed to enhance early disease detection and improve patient outcomes. Founded in 2007, Quanterix is supported by prominent life science investors, positioning it to address significant unmet medical needs and contribute to advancements in healthcare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.